Fact CheckerSign in

NCT06421753Completed

Efficiency of Spatially Distributed Sequential Stimulation (Sdss) for Functional Electrical Stimulation (FES) of Upper Motor Neuron Syndrome (UMR) Patients

Source: ClinicalTrials.gov · Last updated 19 Sept 2025

Brief summary (registry, in English)

To determine whether Spatially Distributed Sequential Functional Electrical Stimulation is more effective than Standard Electrical Stimulation During Functional Electrical Stimulation in Upper Motor Neuron Patients

Status (registry)
Completed
Study type
Interventional
Enrollment
10 (actual)
First submitted
14 May 2024
Start date
16 May 2024
Primary completion date
31 Dec 2024
Lead sponsor
UGECAM Rhône-Alpes
NCT number
NCT06421753

What you commit to

  • Study type: Interventional
  • Participants enrolled: 10
  • From 16 May 2024 to the primary completion date, 31 Dec 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • major cognitive comprehension disorders that could compromise understanding of the protocol and the smooth running of the study
  • cardiac pacemaker and other contraindications relating to the use of electrostimulation (in particularly "deep vein thrombosis")
  • persons deprived of their liberty, persons subject to psychiatric care and persons admitted to a health or social establishment for purposes other than that of clinical investigation;

Other

  • spasticity of the lower limbs making flexion/extension movement difficult
  • participation in another study
  • pregnancy
  • people with the following legal and administrative states or situations:
  • people placed under judicial protection;
  • unemancipated minors;
  • people who are not affiliated to a social security scheme or beneficiaries of such a scheme

Who the study is looking for

  • Patients with Upper Motor Neuron syndrome:
  • adult (\> 18 years)
  • motor deficit due to an acquired traumatic or neurodegenerative motor deficiency of the central nervous system (MRC\<4/5)
  • stable clinical condition, particularly on the cardiovascular level (recent assessment by a cardiologist with stress test)
  • non denervated muscles
  • tolerant to muscle electrical stimulation
  • having given written consent
  • able to cycle 30 minutes with FES-cycling

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
SMR Val Rosay
Coordinator of this site? Confirm its status
Saint-Didier-au-Mont-d'OrFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.